| Analyzing Pulmonary Nodules to Spot Lung Cancer in Low-Dose CT scans |
Cheng He |
Mirxes Labs Pte. Ltd., Singapore |
NLST |
Sep 8, 2022 |
NLST-958 |
| Analyzing the Utility of Smoking Cessation Requirements in the Morbidity and Mortality of Current and Former Smokers Undergoing Lung Resection |
Robert Van Haren |
University of Cincinnati Medical Center |
NLST |
Jun 17, 2024 |
NLST-1262 |
| An analysis into the association between diet, BMI, diabetes, lifestyle factors and patient demographics on thyroid cancer incidence and mortality. |
Tharakeswari Selvakumar |
Rutgers New Jersey Medical School |
PLCO |
Jun 21, 2021 |
PLCO-795 |
| An analysis of body mass index trajectories in relation to esophageal and gastric cardia adenocarcinoma in the PLCO and NIH-AARP cohorts |
Michael Cook |
NCI, DCEG, HREB |
PLCO |
Jun 23, 2014 |
PLCO-92 |
| An Analysis of Design and Evaluation Metrics in Studies Using AI to Predict Future Cancer from Medical Imaging |
Bhramar Mukherjee |
Yale University |
NLST |
Feb 19, 2025 |
NLST-1388 |
| An analysis of the association between genetic variants and mitochondrial DNA copy number. |
Sonja Berndt |
NCI |
PLCO |
Apr 3, 2015 |
PLCO-140 |
| An artificial intelligence tool for therapeutic optimization in early invasive breast cancer patients. |
Grégoire Gessain |
Spotlight Medical |
PLCO |
Dec 4, 2024 |
PLCOI-1753 |
| An Econometric Evaluation of Prostate Cancer Treatments |
Michael Grossman |
CUNY and NBER |
PLCO |
Oct 20, 2014 |
PLCO-108 |
| A nested case-control study from NLST to evaluate a multiplex protein biomarker-based immunoassay for the early detection of bladder cancer |
Charles Rosser |
Cedars-Sinai Medical Center |
NLST |
Nov 21, 2024 |
NLST-1360 |
| A Nested Case-Control Study of Benzoquinone-Protein Adducts and Acute Non-Lymphocytic Leukemia |
Quing Lan |
NCI, DCEG, OEEB |
PLCO |
Jul 1, 2006 |
2006-0165 |
| A nested case-control study of circulating per- and polyfluoroalkyl substances (PFAS) and ovarian and endometrial cancers in the Prostate, Lung, Colorectal and Ovarian Cancer Screening Trial |
Rena Jones |
National Cancer Institute |
PLCO |
Dec 27, 2019 |
2019-1010 |
| A nested case-control study of serum levels of polyfluoroalkyl chemicals (PFCs) and renal cell carcinoma among participants in the Prostate, Lung, Colorectal and Ovarian Cancer Screening Trial |
Jonathan Hofmann |
National Cancer Institute |
PLCO |
Sep 28, 2017 |
2017-0027 |
| An evaluation of SNP frequency, aspirin resistance, and adenoma/colorectal cancer risk in the PLCO study |
Holli Loomans-Kropp |
The Ohio State University |
PLCO |
May 9, 2022 |
PLCO-978 |
| An evaluation of the association between aspirin and NSAID use and changes in body mass index on gastrointestinal cancer incidence and mortality |
Holli Loomans-Kropp |
The Ohio State University |
PLCO |
Feb 15, 2022 |
PLCO-907 |
| A new mathematical model for the computation of optimal cancer surveillance schedules |
Johannes Reiter |
Stanford University |
NLST |
Feb 7, 2020 |
NLST-636 |
| A new mathematical model for the computation of optimal screening frequencies for lung and colorectal cancer |
Johannes Reiter |
Stanford University |
PLCO |
Feb 7, 2020 |
PLCO-581 |
| A new method to estimate the predictive value in a screening program |
Jian-Lun Xu |
NCI |
PLCO |
Feb 7, 2020 |
PLCO-580 |
| A New Prediction Model for Pathological Stages and Treatments for Patients with Prostate Cancer |
Alfadil Hamdan |
Sudan University |
PLCO |
Jun 27, 2018 |
PLCO-377 |
| A new standardized incidence ratio metric for second primary cancer among cancer survivors by accounting for competing risks |
Summer Han |
Stanford University School of Medicine |
PLCO |
Dec 18, 2023 |
PLCO-1419 |
| An examination of the relationship between specific driver mutations, target drugs, and immunotherapies in non-small cell lung cancer survival outcomes. |
Lauren Connell |
Independent |
PLCO |
Nov 17, 2020 |
PLCO-691 |
